Latest 30 News in the Life Sciences Industry
GlobeNewswire
Novartis Fabhalta® (iptacopan) receives FDA traditional approval as first and only complement inhibitor to significantly slow kidney function decline in primary IgAN
17 Jul 2026
GlobeNewswire
TaiMed Biologics (4147) Receives TFDA Drug License Collection Notice for Trogarzo, Marking the Final Step Toward Commercial Launch in Taiwan
08 Jul 2026
GlobeNewswire
SPRINT® PNS Publication Highlights Sustained Benefits in Low Back Pain Patients
07 Jul 2026
GlobeNewswire
Nu-Tek BioSciences Present Cell Nutrient Innovation, Raw Material Expertise at SIMB 2026
07 Jul 2026
GlobeNewswire
Novartis agrees to acquire Myricx Bio, advancing next-generation antibody-drug conjugate innovation with a novel NMTi payload, expanding options for cancer patients
06 Jul 2026
GlobeNewswire
Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)
02 Jul 2026
PR Newswire Association LLC.
International Health Innovation & Exchange Association (IHIEA) Launches in Hong Kong and Unveils Six-Point Action Blueprint
29 Jun 2026
GlobeNewswire
EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives
24 Jun 2026
PR Newswire Association LLC.
BIO Asia-Taiwan Investment Summit to Showcase 27 Startups Before Global Investors
24 Jun 2026
GlobeNewswire
Research Collaboration Secured to Evaluate AI-Driven Cardiac Risk Stratification in Cancer Patients
12 Jun 2026
GlobeNewswire
Novartis RemIND data at EAACI show Rhapsido® potential as first targeted therapy for chronic inducible urticaria (CIndU)
12 Jun 2026
GlobeNewswire
Novartis delpacibart braxlosiran (del-brax) Phase I/II study in facioscapulohumeral muscular dystrophy (FSHD) meets primary biomarker endpoint
11 Jun 2026
GlobeNewswire
Data Published in Interventional Pain Medicine Indicates Participants Who Received SPRINT PNS as Prescribed Were Three Times More Likely to Achieve Meaningful Pain Relief
10 Jun 2026
GlobeNewswire
Novartis to highlight Rhapsido® data across multiple immune-mediated diseases at EAACI Congress 2026
08 Jun 2026
GlobeNewswire
Novartis IgAN data in The Lancet show clinically meaningful slowing of kidney function decline with Vanrafia® over 2.5 years
04 Jun 2026
PR Newswire Association LLC.
Foresee Pharmaceuticals Appoints Brian J. Groch as Chief Commercial Officer to Spearhead Commercial Launch of FP-001 42 mg for Central Precocious Puberty
09 Jul 2026
PR Newswire Association LLC.
C-Ray Therapeutics Receives Radiopharmaceutical Manufacturing Authorization under China's MAH Framework
25 Jun 2026
PR Newswire Association LLC.
KrystoLens from Brain Navi Receives TFDA Certification, Set to Enter Taiwan Market
03 Jun 2026
PR Newswire Association LLC.
Foresee Pharmaceuticals Announces Completion of Casppian Phase 3 Study with Last Patient Last Visit and Confirms Topline Results: 94% of Patients Achieve LH Suppression with 6-Month Dosing Interval of Leuprolide Mesylate, also the acceptance of Caspp
27 May 2026
PR Newswire Association LLC.
Beyond the Millimeter: NaoTrac Redefines Precision Standards via Intelligent Surgical Navigation
26 May 2026
PR Newswire Association LLC.
Gene Solutions Showcases AI-Powered Multi-Omics Liquid Biopsy Innovations at TJCC 2026: Advancing Precision Oncology in Taiwan
22 May 2026
PR Newswire Association LLC.
Johnson & Johnson Launches 'Gut Tunnel' Experience in Singapore to Highlight the Importance of Endoscopic Remission in IBD
18 May 2026
PR Newswire Association LLC.
EirGenix Advances into CPHI Japan, Capitalizing on Market Trends to Deepen Its Strategic Footprint in Japan
29 Apr 2026
PR Newswire Association LLC.
Quest International Expands European Service Footprint with New ISO Registered Service Repair Center and Warehouse in Bornem, Belgium
22 Apr 2026
Upcoming Events All Events
- July 2026
- Taipei: BIO Asia-Taiwan
- August 2026
- Online: Biotechgate Digital Partnering August 2026
- September 2026
- Marina Bay Sands: Asia Bio Partnering Forum